Last updated: 24 July 2019 at 6:22pm EST

Robert Cawthorn Net Worth




The estimated Net Worth of Robert Cawthorn is at least $56.1 Milion dollars as of 27 January 2004. Robert Cawthorn owns over 5,000 units of Charles River Laboratories International stock worth over $55,502,253 and over the last 21 years Robert sold CRL stock worth over $570,850.

Robert Cawthorn CRL stock SEC Form 4 insiders trading

Robert has made over 2 trades of the Charles River Laboratories International stock since 2004, according to the Form 4 filled with the SEC. Most recently Robert sold 5,000 units of CRL stock worth $195,350 on 27 January 2004.

The largest trade Robert's ever made was selling 10,000 units of Charles River Laboratories International stock on 21 January 2004 worth over $375,500. On average, Robert trades about 3,000 units every 1 days since 2003. As of 27 January 2004 Robert still owns at least 286,700 units of Charles River Laboratories International stock.

You can see the complete history of Robert Cawthorn stock trades at the bottom of the page.



Insiders trading at Charles River Laboratories International

Over the last 22 years, insiders at Charles River Laboratories International have traded over $220,588,205 worth of Charles River Laboratories International stock and bought 18,392 units worth $3,841,397 . The most active insiders traders include James C Foster, Richard F Wallman oraz David P Johst. On average, Charles River Laboratories International executives and independent directors trade stock every 14 days with the average trade being worth of $2,223,188. The most recent stock trade was executed by Joseph W La Plume on 8 August 2024, trading 1,780 units of CRL stock currently worth $354,861.



What does Charles River Laboratories International do?

charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro



Complete history of Robert Cawthorn stock trades at Charles River Laboratories International

Osoba
Trans.
Transakcja
Łączna cena
Robert Cawthorn
Dyrektor
Sprzedaż $195,350
27 Jan 2004
Robert Cawthorn
Dyrektor
Sprzedaż $375,500
21 Jan 2004


Charles River Laboratories International executives and stock owners

Charles River Laboratories International executives and other stock owners filed with the SEC include: